Novartis to seek speedy approval for Covid drug after positive trials
In lab tests the drug maintained its antiviral activity against all variants of concern
Covid stockpiling of medicines boosts profit at Swiss group Novartis
Company running coronavirus trial on its hydroxychloroquine drug after Donald Trump intervention
Novartis hands investors Alcon spin-off and $5bn share buyback
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices